|
Q2 FY2024
As of Sep 2, 2023
|
Q1 FY2024
As of Jun 3, 2023
|
Q4 FY2023
As of Mar 4, 2023
|
Q3 FY2023
As of Nov 26, 2022
|
Q2 FY2023
As of Aug 27, 2022
|
Q1 FY2023
As of May 28, 2022
|
Q4 FY2022
As of Feb 26, 2022
|
Q3 FY2022
As of Nov 27, 2021
|
Q2 FY2022
As of Aug 28, 2021
|
Q1 FY2022
As of May 29, 2021
|
Q4 FY2021
As of Feb 27, 2021
|
Q3 FY2021
As of Nov 28, 2020
|
Q2 FY2021
As of Aug 29, 2020
|
Q1 FY2021
As of May 30, 2020
|
Q4 FY2020
As of Feb 29, 2020
|
Q3 FY2020
As of Nov 30, 2019
|
Q2 FY2020
As of Aug 31, 2019
|
Q1 FY2020
As of Jun 1, 2019
|
Q4 FY2019
As of Mar 2, 2019
|
Q3 FY2019
As of Dec 1, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories, net of LIFO reserve of $554,932 and $539,932 | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangibles, net | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Current maturities of long-term debt and lease financing obligations | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued salaries, wages and other current liabilities | ||||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, less current maturities | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Lease financing obligations, less current maturities | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' deficit: | ||||||||||||||||||||
| Common stock, par value $1 per share; 75,000 shares authorized; shares issued and outstanding 56,486 and 56,629 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total liabilities and stockholders' deficit | ||||||||||||||||||||
Loading...
